Search Results

WP1130 Evaluation Sample  | 99.2%

APEXBIO TECHNOLOGY LLC

Deubiquitinase (DUB) inhibitor, Cell permeable Ubiquitination/ Proteasome|DUB

More Information Supplier Page

×

WP1130

WP1130 5mg  | 99.2%

APEXBIO TECHNOLOGY LLC

Deubiquitinase (DUB) inhibitor, Cell permeable Ubiquitination/ Proteasome|DUB

More Information Supplier Page

×

WP1130

WP1130 10mg  | 99.2%

APEXBIO TECHNOLOGY LLC

Deubiquitinase (DUB) inhibitor, Cell permeable Ubiquitination/ Proteasome|DUB

More Information Supplier Page

×

WP1130

Neratinib (HKI-272) 5mg  | 99.81%

APEXBIO TECHNOLOGY LLC

HER2/EGFR inhibitor,potent and irreversible JAK/STAT Signaling|EGFR

More Information Supplier Page

×

Neratinib (HKI-272)

Neratinib (HKI-272) Evaluation Sample  | 99.81%

APEXBIO TECHNOLOGY LLC

HER2/EGFR inhibitor,potent and irreversible JAK/STAT Signaling|EGFR

More Information Supplier Page

×

Neratinib (HKI-272)

Neratinib (HKI-272) 10mM (in 1mL DMSO)  | 99.81%

APEXBIO TECHNOLOGY LLC

HER2/EGFR inhibitor,potent and irreversible JAK/STAT Signaling|EGFR

More Information Supplier Page

×

Neratinib (HKI-272)

Cisplatin 100mg  | 99.84%

APEXBIO TECHNOLOGY LLC

Inhibits DNA synthesis,chemotherapy drug Apoptosis|Caspase

More Information Supplier Page

×

Cisplatin

PF-00562271 25mg  | 98.16%

APEXBIO TECHNOLOGY LLC

FAK/Pyk2 inhibitor,potent and ATP-competitive Tyrosine Kinase|FAK

More Information Supplier Page

×

PF-00562271

Dacomitinib (PF299804, PF299) 5mg  | 98%

APEXBIO TECHNOLOGY LLC

HER inhibitor JAK/STAT Signaling|EGFR

More Information Supplier Page

×

Dacomitinib (PF299804, PF299)

Dacomitinib (PF299804, PF299) 25mg  | 98%

APEXBIO TECHNOLOGY LLC

HER inhibitor JAK/STAT Signaling|EGFR

More Information Supplier Page

×

Dacomitinib (PF299804, PF299)